Back to Search Start Over

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.

Authors :
Peersen, Kari
Munkhaugen, John
Sverre, Elise
Kristiansen, Oscar
Fagerland, Morten
Vethe, Nils Tore
Perk, Joep
Husebye, Einar
Dammen, Toril
Source :
BMC Cardiovascular Disorders; 12/16/2021, Vol. 21 Issue 1, p1-9, 9p
Publication Year :
2021

Abstract

<bold>Background: </bold>To compare clinical and psychological factors among patients with self-perceived statin-associated muscle symptoms (SAMS), confirmed SAMS, and refuted SAMS in coronary heart disease patients (CHD).<bold>Methods: </bold>Data were obtained from a cross-sectional study of 1100 CHD outpatients and a study of 71 CHD outpatients attending a randomized, double-blinded, placebo-controlled, crossover study to test effects of atorvastatin 40 mg/day on muscle symptom intensity. Clinical and psychosocial factors were compared between patients with and without SAMS in the cross-sectional study, and between patients with confirmed SAMS and refuted SAMS in the randomized study.<bold>Results: </bold>Bilateral, symmetric muscle symptoms in the lower extremities during statin treatment were more prevalent in patients with confirmed SAMS compared to patients with refuted SAMS (75% vs. 41%, pā€‰=ā€‰0.01) in the randomized study. No significant differences in psychological factors (anxiety, depression, worry, insomnia, type D personality characteristics) were detected between patients with and without self-perceived SAMS in the cross-sectional study, or between patients with confirmed SAMS and refuted SAMS, in the randomized study.<bold>Conclusions: </bold>Patients with confirmed SAMS more often present with bilateral lower muscle symptoms compared to those with refuted SAMS. Psychological factors were not associated with self-perceived SAMS or confirmed SAMS. A careful pain history and a search for alternative causes of muscle symptoms are likely to promote communication in patients with SAMS, and may reduce the risk for statin discontinuation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712261
Volume :
21
Issue :
1
Database :
Complementary Index
Journal :
BMC Cardiovascular Disorders
Publication Type :
Academic Journal
Accession number :
154173368
Full Text :
https://doi.org/10.1186/s12872-021-02422-7